Skip to main content

Long term treatment of SDAT patients with pyritinol

  • Chapter

Part of the Key Topics in Brain Research book series (KEYTOPICS)

Summary

A group of 26 patients with the clinical diagnosis of Senile Dementia of Alzheimer’s type (SDAT) was randomly assigned in a double blind cross-over trial of pyritinol versus placebo. Psychiatric and neurological examination, psychometric testing and regional cerebral blood flow measurements were used to assess the effects of medication. Pyritinol had a beneficial effect on cognitive performance which was sustained during the long term follow up of one year.

Keywords

  • Word Pair
  • Regional Cerebral Blood Flow
  • Target Sentence
  • Demented Patient
  • Soft Neurological Sign

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-7091-3396-5_64
  • Chapter length: 10 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   84.99
Price excludes VAT (USA)
  • ISBN: 978-3-7091-3396-5
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   109.00
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cohen G (1979) Language and comprehension in old age. Cognitive Psychology 11: 412–429

    PubMed  CrossRef  CAS  Google Scholar 

  • Cohen G, Faulkner D (1981) Memory for discourse in old age. Discourse Processes 4: 253–265

    CrossRef  Google Scholar 

  • Cooper AJ, Magnus RV (1980) A placebo-controlled study of pyritinol ( Encephabol) in dementia. Pharmatherapeutica 2: 317–323

    PubMed  CAS  Google Scholar 

  • Erzigkeit H (1986) Der Syndrom-Kurztest zur Erfassung von Aufmerksamkeitsund Gedächtnisstörungen. Vless, Vaterstetten

    Google Scholar 

  • Greiner HE, Haase AF, Seyfried CA (1988) Biochemical models for the study of the mechanism of action of an encephalotropic drug. In: Kanowski S, Ladurner G (eds) Dementielle Erkrankungen im Alter. Pathogenetische Modelle und Therapeutische Wirklichkeit. Thieme, Stuttgart, S 45–51

    Google Scholar 

  • Hamouz W (1977) The use of pyritinol in patients with moderate to severe organic psychosyndrome. Pharmatherapeutica 1: 398–403

    Google Scholar 

  • Herrmann WM, Kern U, Rohmel J (1986) The effects of pyritinol on functional deficits of patients with organic mental disorders. Pharmacopsychiatry 19: 378–385

    PubMed  CrossRef  CAS  Google Scholar 

  • Hoyer S, Oesterreich K, Stoll KD (1977) Effects of pyritinol-HC1 on blood flow and oxidative metabolism of the brain in patients with dementia. Drug Res 27: 671–674

    CAS  Google Scholar 

  • Knezevic S, Mubrin Z, Risberg J, Vucinic G, Spilich G, Gubarev N, Wannenmacher W (1989) Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements. Clin Psychopharmacol 4: 25–38

    CrossRef  CAS  Google Scholar 

  • Martin KJ, Vyas S (1987) Increase in acetylcholine concentration in the brain of “old” rats following treatment with pyrithioxine ( Encephabol ). Br J Pharmacol 90: 561–569

    Google Scholar 

  • Maximilian VA, Brawanski A (1988) Functional and vascular challenge procedures during noninvasive rCBF measurements. In: Knezevic S, Maximilian VA, Mubrin V, Prohovnik I, Wade J (eds) Handbook of regional cerebral blood flow. Lawrence Erlbaum Associates, Hove and London, pp 79–121

    Google Scholar 

  • Mubrin Z, Knezevic S, Barac B, Poljakovic Z, Pudar-Klein M, Katic Z (1985a) Effect of mental activation on regional cerebral blood flow (rCBF) changes in patients with cerebrovascular disease. Neurologija (Zagreb) 31: 107–124

    Google Scholar 

  • Mubrin Z, Knezevic S, Barac B, Gubarev N, Lazic M, Liscic R, Vidosic S (1985b) Distinct rCBF pattern during different types of short-term memory activation. In: Hartmann A, Hoyer S (eds) Cerebral blood flow and metabolism measurement. Springer, Berlin Heidelberg New York Tokyo, pp 81–87

    CrossRef  Google Scholar 

  • Obrist WD, Thompson HK, Wang HS, Wilkinson WE (1975) Regional cerebral blood flow estimated by 133Xenon inhalation. Stroke 6: 245–256

    PubMed  CrossRef  CAS  Google Scholar 

  • Oswald WD, Oswald B, Grobe D, Lukaschek K, Sappa J, Fleischmann UM (1986) Recent approaches in the treatment and assessment of psychoorganic brain-syndromes. A double-blind study with pyritinol. In: Ramos GG, Herrmann WM, Otero E, Toledano A (eds) Advances in the field of cerebrovascular disease. Egrat, Madrid, pp 88–96

    Google Scholar 

  • Pavlik A, Benesova O, Dlohozkova N (1987) Effects of nootropic drugs on brain cholinergic and dopaminergic transmission. Act Nery Sup 29: 62–65

    CAS  Google Scholar 

  • Risberg J (1980) Regional cerebral blood flow measurements by 133Xe-inhalation: methodology and applications in neuropsychology and psychiatry. Brain Lang 9: 9–34

    PubMed  CrossRef  CAS  Google Scholar 

  • Risberg J (1985) Application of the nontraumatic xenon 133 method in neuropsychiatry. In: Hartmann A, Hoyer S (eds) Cerebral blood flow and metabolism measurement. Springer, Berlin Heidelberg New York Tokyo, pp 72–80

    CrossRef  Google Scholar 

  • Risberg J, Ali Z, Wilson EM, Wills EL, Halsey JH Jr (1975) Regional cerebral blood flow by 133Xenon inhalation. Preliminary evaluation of an initial slope index in patients with unstable flow compartments. Stroke 6: 142–148

    Google Scholar 

  • Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer’s disease. Am J Psychiatry 141: 1356–1365

    PubMed  CAS  Google Scholar 

  • Rosen WG, Terry RD, Fuld PA, et al (1980) Pathological verification of ischemic score in differentiation of demential. Ann Neurol 7: 486–488

    PubMed  CrossRef  CAS  Google Scholar 

  • Spilich GJ (1983) Life-span components of text processing: structural and procedural differences. Journal of Verbal Learning and Verbal Behavior 22: 231–244

    CrossRef  Google Scholar 

  • Spilich GJ (1985) Discourse comprehension across the span of life. In: Charness N (ed) Aging and human performance. Wiley, New York, pp 143–190

    Google Scholar 

  • Spilich GJ, Voss JF (1983) Contextual effects upon text memory for young, aged-normal, and aged memory-impaired individuals. Exp Aging Res 9: 45–49

    PubMed  CAS  Google Scholar 

  • Venn RD (1983) The Sandoz clinical assessment geriatric (SCAG) scale. Gerontology 29: 185–198

    PubMed  CrossRef  CAS  Google Scholar 

  • Wechsler D (1945) A standardized memory scale for clinical use. J Psychol 27: 91–94

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 1990 Springer-Verlag Wien

About this chapter

Cite this chapter

Knezevic, S., Mubrin, Z., Spilich, G., Vucinic, G., Wannenmacher, W. (1990). Long term treatment of SDAT patients with pyritinol. In: Maurer, K., Riederer, P., Beckmann, H. (eds) Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3396-5_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3396-5_64

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82197-8

  • Online ISBN: 978-3-7091-3396-5

  • eBook Packages: Springer Book Archive